{Reference Type}: Letter
{Title}: Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells.
{Author}: Maslah N;Rety S;Bonnamy M;Aguinaga L;Huynh T;Parietti V;Giraudier S;Fenaux P;Cassinat B;
{Journal}: Leukemia
{Volume}: 38
{Issue}: 7
{Year}: 2024 Jul 22
{Factor}: 12.883
{DOI}: 10.1038/s41375-024-02281-z